Back to Search
ANGELA CORBIN, MD
MD
Internal Medicine Physician
NPI: 1528134814Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
0101222273(VA)MD18241(DC)D35421(MD)
Research & Publications (20)
A national prevalence study of pressure ulcers in French hospital inpatients.
PMID 18833894·J Wound Care·2008
8-other
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.
PMID 18559973·Blood·2008
7-preclinical
An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia.
PMID 18509354·Leukemia·2008
5-case
SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib.
PMID 18367669·Proc Natl Acad Sci U S A·2008
8-other
Improving health status of homeless patients at a nurse-managed clinic in the Midwest USA.
PMID 18266719·Health Soc Care Community·2008
8-other
Direct visualization of spatial and temporal patterns of antimicrobial action within model oral biofilms.
PMID 18223108·Appl Environ Microbiol·2008
8-other
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.
PMID 18025156·Blood·2008
8-other
Budvicia aquatica sepsis in an immunocompromised patient following exposure to the aftermath of Hurricane Katrina.
PMID 17644725·J Med Microbiol·2007
5-case
The 360-degree approach. EHRs are only a first step in what should be an effort to integrate clinical and financial applications.
PMID 17518240·Healthc Inform·2007
8-other
Characterization of murine JAK2V617F-positive myeloproliferative disease.
PMID 17145859·Cancer Res·2006
7-preclinical
Health care needs of homeless adults at a nurse-managed clinic.
PMID 17064232·J Community Health Nurs·2006
8-other
Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.
PMID 16880519·Mol Cell Biol·2006
7-preclinical
Velopharyngeal anatomy in 22q11.2 deletion syndrome: a three-dimensional cephalometric analysis.
PMID 16854203·Cleft Palate Craniofac J·2006
8-other
Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
PMID 16609040·Clin Cancer Res·2006
4-observational
Establishment of a murine model of aggressive systemic mastocytosis/mast cell leukemia.
PMID 16543062·Exp Hematol·2006
7-preclinical
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.
PMID 16397263·Cancer Res·2006
7-preclinical
Targeted CML therapy: controlling drug resistance, seeking cure.
PMID 16343892·Curr Opin Genet Dev·2006
6-review
Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells.
PMID 16167056·Leukemia·2005
8-other
A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib.
PMID 16151465·Leukemia·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2101 EAST JEFFERSON STREET, KAISER PERMANENTE
ROCKVILLE, MD 20852 - Phone
- (301) 816-2424
Quick Facts
- NPI
- 1528134814
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile